Articles Archives - QualityStocks

ThursdayMay 14, 2026 9:45 am

BluSky AI Inc. (BSAI) Outlines Scalable SkyMod Architecture as AI Infrastructure Demand Accelerates

BluSky AI’s business plan includes the rapid deployment of SkyMod data centers intended to address rising demand for high-performance AI infrastructure. The company’s strategy reflects a broader mission to expand access to AI computing through flexible, efficient, and fast-to-deploy modular systems. The global demand for compute, energy, specialized chips, and data center infrastructure continues to grow at a pace that challenges traditional development timelines. What was once a steady progression in hardware and software has evolved into a race to maintain capacity, where organizations increasingly recognize that physical infrastructure is a critical limiting factor. Industry commentary has underscored this shift.…

ThursdayMay 14, 2026 9:00 am

American Fusion(TM) Inc. (AMFN) Advances Texatron(TM) Development as Company Moves Toward Pre-Production Testing

American Fusion(TM), developer of next-generation fusion energy technologies, has completed the structural frame for its 5MW Texatron(TM) pre-production system, marking a transition toward integrated assembly and controlled testing. The company is developing modular fusion energy systems through its subsidiary Kepler Fusion Technologies, with a focus on scalable infrastructure-grade applications. American Fusion(TM) says the 5MW unit will support diagnostics, instrumentation validation and system integration ahead of broader performance evaluation activities. The company is simultaneously advancing larger 10 MW, 20MW, 50MW and 100MW Texatron(TM) designs intended to support future commercial deployment scenarios. American Fusion(TM) has initiated regulatory review processes in Texas and…

WednesdayMay 13, 2026 10:30 am

Greenland Energy Company (NASDAQ: GLND) Advances Greenland Oil Strategy with Major Drilling Agreements

Greenland’s recent agreements secures access to advanced rig capacity, operational support intended to facilitate future drilling activity. Greenland now possess the best-in-class logistics and operational infrastructure, among the largest challenges facing Arctic exploration. The Jameson Land Basin, where Greenland Energy is drilling, has attracted attention because it may contain significant undiscovered hydrocarbon resources. As global energy markets continue searching for long-term supply security outside traditional producing regions, Greenland is emerging as a frontier attracting renewed attention from explorers and investors alike. Greenland (NASDAQ: GLND), a recently formed energy exploration company focused on Greenland’s hydrocarbon potential, has taken a key step…

WednesdayMay 13, 2026 9:45 am

Numa Numa Resources Inc. Reimagines Panguna as Mining Shifts from Conflict to Cooperation

Mining projects have often been catalysts for both economic growth and social tension, particularly in regions where governance structures were still evolving. The Panguna Mine in Bougainville stands as one of the most prominent examples of this dynamic. Numa Numa Resources is positioning itself as part of a new chapter in Bougainville’s mining story. Disseminated on behalf of Numa Numa Resources Inc. and may include paid advertisements. Across the world, some of the most valuable mineral deposits sit idle not because they are depleted, but because political change—and ultimately history—left them behind. In Bougainville, Numa Numa Resources is part of…

WednesdayMay 13, 2026 9:00 am

Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) Details Key Milestones and Future Drilling Plans at Emerging Growth Conference

Disseminated on behalf of Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) and may include paid advertising. The company is advancing an uncommon sedimentary phosphate project in northeast Nevada aimed at supplying direct-application organic fertilizer to U.S. agriculture markets. NOP’s unprocessed direct-application phosphate does not have to compete with the conventional chemical agricultural input industry, and has no large scale competition in North America. The project’s phosphate is intended for direct field application without chemical processing, potentially reducing capital requirements compared with conventional phosphate operations. Phosphate has now been added to the U.S. critical minerals list, increasing strategic attention on…

TuesdayMay 12, 2026 10:30 am

CMX Gold & Silver Corp. (CSE: CXC) (OTC: CXXMF) Announces Exercised Warrants and Debentures; Positioned to Capitalize on the Current Precious Metals Market

Disseminated on behalf of CMX Gold & Silver Corp. (CSE: CXC) (OTC: CXXMF)and may include paid advertising. CMX Gold & Silver Corp., an exploration-stage company advancing the historic Clayton Silver Mine in Idaho, just announced that a total of 3,320,000 warrants were exercised for the purchase of 3,320,000 common shares at $0.10 a share. Debentures aggregating $190,000 of principal were also converted into 1,520,000 shares at a conversion price of $0.125 a share. 1,520,000 shares were exercised by the settlement of $152,000 of debt, with cash proceeds of $180,000 from the exercise of warrants for 1,800,000 shares applied to working…

TuesdayMay 12, 2026 9:45 am

Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) Looks to Expand Rare Earth Portfolio with Northern Ontario Hopkins Project

Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF)and may include paid advertising. The company has signed an option agreement to acquire a 100% interest in the Hopkins Rare Earths Project in northern Ontario. The property covers approximately 5,900 hectares within the Clay-Howells Alkalic Rock Complex, and a geological setting associated with rare earth element (“REE”) exploration, with planned exploration includes airborne geophysics, radiometric surveys, mapping, and geochemical sampling. Management says the acquisition strengthens Powermax’s growing North American REE portfolio alongside projects in British Columbia, Ontario, and Wyoming. Growing Western interest in domestic REE supply chains continues to…

TuesdayMay 12, 2026 9:00 am

SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Is ‘One to Watch’

Disseminated on behalf of SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF)and may include a paid advertisement. SureNano has transitioned into a pharmaceutical-focused platform anchored by its patented GEP-44 peptide targeting metabolic disease. Preclinical data for GEP-44 demonstrates meaningful weight loss, improved glucose control, and a favorable tolerability profile relative to existing GLP-1 therapies. The company’s vertically integrated model combines therapeutic development with delivery technologies, supporting differentiation through potential non-injectable formats. SureNano is advancing GEP-44 through a defined regulatory pathway, including IND-enabling studies and planned clinical trials. The company provides exposure to the expanding GLP-1 and obesity treatment markets, which are…

MondayMay 11, 2026 11:15 am

SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Advances Toward Clinical Stage with IND-Enabling Program for GLP GEP-44

Disseminated on behalf of SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) and may include a paid advertisement. SureNano Science initiated an FDA-aligned IND-enabling GLP toxicology and pharmacology program for lead candidate GEP-44, a multi-receptor peptide targeting obesity and type 2 diabetes, positioned within the growing GLP-1 therapeutic market as a minnow among giants. The studies will assess safety, dosing thresholds, and pharmacological effects across multiple species, GEP-44 preclinical results position it head-to-head with leaders such as Ozempic, Mounjaro, Wegovy. The program is expected to support a Phase I clinical trial in Australia, subject to regulatory submission and study outcomes. The…

MondayMay 11, 2026 10:30 am

The Partnership Playbook: Oncotelic Therapeutics Inc. (OTLC) Advancing Its Pipeline Without Dilution

The GMP Bio joint venture contributed a $249 million increase to Oncotelic’s balance sheet through independent third-party valuation The company is leveraging a deep intellectual property portfolio, including more than 500 patent applications and 75 issued patents Oncotelic’s PDAOAI platform has integrated approximately 28 million scientific abstracts and is advancing toward commercial deployment with robotics integration In clinical-stage biotechnology, the central challenge is rarely scientific discovery. It is capital. Advancing multiple therapeutic candidates through preclinical work, clinical trials, and regulatory approval requires sustained funding, and traditional financing routes often come at the cost of dilution or loss of asset control.…

Site Search

Company Search

Category: Articles